tiprankstipranks
Trending News
More News >
Crescent Capital BDC (CCAP)
NASDAQ:CCAP
US Market

Crescent Capital BDC (CCAP) Earnings Dates, Call Summary & Reports

Compare
372 Followers

Earnings Data

Report Date
May 13, 2026
Before Open (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.42
Last Year’s EPS
0.45
Same Quarter Last Year
Based on 1 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 25, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a balanced but constructive view: management highlighted durable portfolio fundamentals (diversified, predominantly first-lien, sponsor-backed, strong interest coverage), proactive balance-sheet actions (extended debt maturities, ample liquidity), meaningful spillover income and continued origination activity. Headwinds included modest NAV decline, a small uptick in nonaccruals (partially remediated in January), and pressure on yields and NII from lower base rates. Management is proactively reviewing dividend and fee frameworks to bolster long-term earnings durability, and expects to provide a fuller update next quarter.
Company Guidance
Management guided that Q4 net investment income was $0.45 per share (down from $0.46 Q3) and covered the base dividend by 107%; the Board declared a $0.42/share Q1 2026 cash dividend (payable April 15, record March 31). NAV was $19.10 at 12/31 (vs. $19.28 at 9/30), total investments at fair value were ~$1.6B across 184 companies (avg position ~0.6%), with 91% first‑lien, 99% sponsor‑backed, a ~40% weighted avg LTV at origination, 71% of loans with covenants and a weighted avg portfolio risk rating of 2.1 (86% rated 1–2). Activity and credit metrics: Crescent’s private credit platform committed >$6.5B in 2025 (>$1.7B in Q4); Q4 gross deployment was $71M (5 new platforms $29M at a weighted avg spread ~490 bps; $42M add‑ons), Q4 exits/sales/repayments ~ $78M (net realizations ≈ $7M); yield at cost fell 40 bps QoQ to 10%, interest coverage improved to 2.2x, and nonaccruals rose to 4.1% of cost / 2.0% of fair value (pro forma after January actions ~3.2% cost / 1.4% FV). Capitalization and liquidity: total net assets $706M, NAV $19.10, quarter‑end debt‑to‑equity 1.25x (1.20x net of cash) within the 1.1–1.3x target, weighted avg stated borrowing rate 5.83% (down from 5.99%), $185M of senior unsecured notes priced (first $135M funded; $50M funds in May), >90% of committed debt now matures in 2028 or later, $242M undrawn capacity and >$30M cash; spillover income is ~ $1.16/share (~3x the base dividend). Management and the Board are reviewing fee structure and base dividend level to shore up long‑term earnings durability and will provide a more fulsome update in May.
Net Investment Income and Dividend Coverage
Reported net investment income (NII) of $0.45 per share in Q4 2025 vs $0.46 prior quarter (≈-2.2%). NII covered the base dividend by 107%; Board declared quarterly cash dividend of $0.42 per share for Q1 2026.
Strong Spillover Income
Spillover income approximately $1.16 per share, nearly 3x the base dividend, providing meaningful supplemental support to earnings during the rate transition.
Portfolio Size and Diversification
Investment portfolio at fair value ≈ $1.6 billion across 184 companies; average investment ≈0.6% of portfolio. 91% first lien, 99% sponsor-backed, weighted average LTV at origination ≈40%, and 71% of portfolio includes covenants.
Deployment and Deal Economics
Gross deployment in Q4 totaled $71 million (5 new platform investments totaling $29 million; $42 million incremental investments). New platform investments carried a weighted average spread of ~490 bps, with Crescent acting as lead or agent.
Yield and Coverage Trends
Weighted average yield on income-producing securities at cost fell by 40 bps Q/Q to 10% (driven by lower base rates), while weighted average interest coverage improved to 2.2x, indicating underlying portfolio earnings resiliency.
Capital Structure and Liquidity Enhancements
Proactively priced $185 million of senior unsecured notes (delayed draw); first $135 million closed in Feb, final $50 million to fund in May. Pro forma, >90% of committed debt now matures 2028 or later, extending maturity profile.
Prudent Leverage and Liquidity
Net debt-to-equity ~1.20x (quarter-end debt-to-equity 1.25x, or 1.2x net of cash), inside target range (1.1x–1.3x). Available liquidity includes ~$242 million undrawn capacity and >$30 million cash.
Active Origination Platform
Crescent private credit platform committed >$6.5 billion in 2025 (including >$1.7 billion in Q4). Existing portfolio served as an active origination channel with add-ons representing over half of transactions.
Realized Gains and Nonaccrual Remediation
Recorded a realized gain from sale of a previously nonaccrual investment (MTS) sold above cost in Q4. Subsequent January actions (one restructure, one sale) materially reduced pro forma nonaccruals.
Sector Expertise—Software & Services
Software & services represent ~20% of the portfolio; long track record (15+ years) with disciplined, cash-flow driven underwriting (first lien only, no ARR loans), and portfolio showing revenue/EBITDA growth and deleveraging.

Crescent Capital BDC (CCAP) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CCAP Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 13, 2026
2026 (Q1)
0.42 / -
0.45
Feb 25, 2026
2025 (Q4)
0.43 / 0.45
0.55-18.18% (-0.10)
Nov 12, 2025
2025 (Q3)
0.47 / 0.46
0.64-28.13% (-0.18)
Aug 13, 2025
2025 (Q2)
0.47 / 0.46
0.59-22.03% (-0.13)
May 14, 2025
2025 (Q1)
0.53 / 0.45
0.63-28.57% (-0.18)
Feb 19, 2025
2024 (Q4)
0.56 / 0.55
0.61-9.84% (-0.06)
Nov 12, 2024
2024 (Q3)
0.58 / 0.64
0.598.47% (+0.05)
Aug 12, 2024
2024 (Q2)
0.58 / 0.59
0.565.36% (+0.03)
May 08, 2024
2024 (Q1)
0.58 / 0.63
0.5416.67% (+0.09)
Feb 21, 2024
2023 (Q4)
0.57 / 0.61
0.5217.31% (+0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CCAP Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 25, 2026
$13.27$13.22-0.38%
Nov 12, 2025
$14.23$13.59-4.50%
Aug 13, 2025
$14.29$14.76+3.29%
May 14, 2025
$15.62$14.94-4.35%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Crescent Capital BDC (CCAP) report earnings?
Crescent Capital BDC (CCAP) is schdueled to report earning on May 13, 2026, Before Open (Confirmed).
    What is Crescent Capital BDC (CCAP) earnings time?
    Crescent Capital BDC (CCAP) earnings time is at May 13, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CCAP EPS forecast?
          CCAP EPS forecast for the fiscal quarter 2026 (Q1) is 0.42.